Janney Montgomery Scott Downgrades Cerulean Pharma (CERU) to Neutral
Tweet
Share
E-mailGet Alerts CERU Hot Sheet
Price: $0.66 --0%
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 26
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 26
Join SI Premium – FREE
Janney Montgomery Scott downgraded Cerulean Pharma (NASDAQ: CERU) from Buy to Neutral with a price target of $1.00 (from $6.00).
For an analyst ratings summary and ratings history on Cerulean Pharma click here. For more ratings news on Cerulean Pharma click here.
Shares of Cerulean Pharma closed at $2.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MongoDB (MDB) PT Raised to $480 at Canaccord
- Aier Eye Hospital Group Co Ltd (300015:CH) PT Lowered to RMB12 at Citi
- China International Marine Containers A (000039:CH) PT Raised to RMB14.10 at Citi
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Janney Montgomery ScottSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
